Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

Similar documents
2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Preventive Care and Screening: Screening for Depression and Follow-Up Plan

Preventive Care and Screening: Influenza Immunization

emeasure Title emeasure Identifier (Measure Authoring Tool) 621 emeasure Version number

American Gastroenterological Association (AGA) Colorectal Cancer (CRC) Screening and Surveillance Measures January 1, 2015 to December 31, 2015

emeasure Version number 0

DIABETIC RETINOPATHY MEASURES GROUP OVERVIEW

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40%

Quality ID #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Age 18 years and older BMI 18.5 and < 25 kg/m 2

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction

Age 18 years and older BMI 18.5 and < 25 kg/m 2

NOA 3rd Party Newsletter PQRS EDITION - Page 1 CONTENTS. Traffic Sheet P.3. Flowsheet & Detailed Directions P.11.

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

Measure #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

Childhood Immunization Status

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

emeasure Title Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

08/02/2019 Follow-Up Care for Children Prescribed ADHD Medication (ADD)

DENOMINATOR: All patients aged 18 years and older seen for at least two visits or at least one preventive visit during the measurement period

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care

2018 CMS Web Interface

Measure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care

Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

Measure #408: Opioid Therapy Follow-up Evaluation National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Quality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

Normal Parameters: Age 65 years and older BMI 23 and < 30 kg/m 2 Age years BMI 18.5 and < 25 kg/m 2

Measure #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

Quality ID #117 (NQF 0055): Diabetes: Eye Exam National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

DESCRIPTION: Percentage of patients aged 5 years and older with a diagnosis of persistent asthma who were prescribed long-term control medication

Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

Measure #72 (NQF 0385): Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients National Quality Strategy Domain: Effective Clinical Care

This is a two-part measure which is paired with Measure #154: Falls: Risk Assessment.

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Measure #279: Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy National Quality Strategy Domain: Effective Clinical Care

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

Quality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

Quality ID #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

Definition: Active injection drug users - Those who have injected any drug(s) within the 12 month reporting period

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Measure #131 (NQF 0420): Pain Assessment and Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Quality ID #39 (NQF 0046): Screening for Osteoporosis for Women Aged Years of Age National Quality Strategy Domain: Effective Clinical Care

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

DESCRIPTION: Percentage of new patients whose biopsy results have been reviewed and communicated to the primary care/referring physician and patient

Quality ID #1 (NQF 0059): Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Guideline scope Hypertension in adults (update)

Quality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care

2013 Hypertension Measure Group Patient Visit Form

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

2019 CMS Web Interface

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 CMS Web Interface

Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

DENOMINATOR: All female patients aged 65 years and older with a diagnosis of urinary incontinence

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Quality ID #224 (NQF 0562): Melanoma: Overutilization of Imaging Studies in Melanoma National Quality Strategy Domain: Efficiency and Cost Reduction

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

Quality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process-High Priority

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

CMS53/AMI 8a: Primary PCI Received Within 90 Minutes of Hospital Arrival

Hypertension JNC 8 (2014)

Transcription:

emeasure Title Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented emeasure Identifier (Measure Authoring Tool) 22 emeasure Version number 5.1.000 NQF Number Not Applicable GUID 9a033a94-3d9b-11e1-8634- 00237d5bf174 Measurement Period Measure Steward Measure Developer Endorsed By Description Copyright January 1, 20XX through December 31, 20XX Centers for Medicare & Medicaid Services (CMS) Quality Insights of Pennsylvania Percentage of patients aged 18 years and older seen during the reporting period who were screened for high blood pressure AND a recommended follow-up plan is documented based on the current blood pressure (BP) reading as indicated Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. Quality Insights of Pennsylvania disclaims all liability for use or accuracy of any Current Procedural Terminology (CPT [R]) or other coding contained in the specifications. CPT (R) contained in the Measure specifications is copyright 2007-2016 American Medical Association. LOINC (R) copyright 2004-2015 [2.54] Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms (R) (SNOMED CT [R]) copyright 2004-2015 [2015-09] International Health Terminology Standards Development Organization. All Rights Reserved. Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM]. Disclaimer These performance measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND. Measure Scoring Measure Type Stratification Risk Adjustment Rate Aggregation Rationale Proportion Process Hypertension is a prevalent condition that affects approximately 66.9 million people in the United States. It is estimated that about 20-40% of the adult population has hypertension; the majority of people over age 65 have a hypertension diagnosis (Appleton SL, et. al., 2012 and Luehr D, et. al., 2012). Winter (2013) noted that 1 in 3 American adults have hypertension and the lifetime risk of developing hypertension is 90% (Winter KH, et. al., 2013). The African American population or non-hispanic Blacks, the elderly, diabetics and those with chronic kidney disease are at increased risk of stroke, myocardial infarction and renal disease. Non-Hispanic Blacks have the highest prevalence at 38.6% (Winter KH, et. al., 2013). Hypertension is a major risk factor for ischemic heart disease, left ventricular hypertrophy, renal failure, stroke and dementia (Luehr D, et. al., 2012). Hypertension is the most common reason for adult office visits other than pregnancy. Garrison (2013) stated that in 2007, 42 million ambulatory visits were attributed to hypertension (Garrison GM and Oberhelman S, 2013). It also has the highest utilization of prescription drugs. Numerous resources and treatment options are available, yet only about 40-50% of the hypertensive patients have their blood pressure under control (<140/90) (Appleton SL, et. al., 2012, Luehr D, et. al., 2012). In addition to medication non-compliance, poor outcomes are also attributed to poor adherence to lifestyle changes such as a low-sodium diet, weight loss, increased exercise and limiting alcohol intake. Many adults find it difficult to continue medications and lifestyle changes when they are asymptomatic. Symptoms of elevated blood pressure usually do not occur until secondary problems arise such as with vascular diseases (myocardial infarction, stroke, heart failure and renal insufficiency) (Luehr D, et. al., 2012). Appropriate follow-up after blood pressure measurement is a pivotal component in preventing the progression of hypertension and the development of heart disease. Detection of marginally or fully elevated blood pressure by a specialty clinician warrants referral to a provider familiar with the management of hypertension and prehypertension. The 2010 ACCF/AHA Guideline for the Assessment of Cardiovascular Risk in Asymptomatic Adults continues to support using a global risk score such as the Framingham Risk Score, to assess risk of coronary heart disease (CHD) in all asymptomatic adults (Greenland P, et. al., 2010). Lifestyle modifications have demonstrated effectiveness in lowering blood pressure (JNC 7, 2003). The synergistic effect of several lifestyle modifications results in greater benefits than

a single modification alone. Baseline diagnostic/laboratory testing establishes if a co-existing underlying condition is the etiology of hypertension and evaluates if end organ damage from hypertension has already occurred. Landmark trials such as ALLHAT have repeatedly proven the efficacy of pharmacologic therapy to control blood pressure and reduce the complications of hypertension. Follow-up intervals based on blood pressure control have been established by the JNC 7 and the USPSTF. Clinical Recommendation Statement Improvement Notation The U.S. Preventive Services Task Force (USPSTF) recommends screening for high blood pressure in adults age 18 years and older. This is a grade A recommendation. Higher score indicates better quality U.S. Preventive Services Task Force (USPSTF) (2007). Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Annals of Internal Medicine; 147(11):783-6 U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute & National High Blood Pressure Education Program (2003). The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7). NIH Publication No. 03-5233 Garrison GM & Oberhelman S (2013). Screening for hypertension annually compared with current practice. Annals of Family Medicine, 11 (2), 116-121. Luehr D, Woolley T, Burke R, Dohmen F, Hayes R, Johnson M, Kerandi H, Margolis K, Marshall M, O'Connor P, Pereira C, Reddy G, Schlichte A & Schoenleber M (2012). Hypertension diagnosis and treatment; Institute for Clinical Systems Improvement health care guideline. Updated November, 2012. Appleton SL, Neo C, Hill C L, Douglas K A & Adams R J (2012). Untreated hypertension: prevalence and patient factors and beliefs associated with under-treatment in a population sample. Journal of Human Hypertension, advance online publication December 13, 2012. Winter K H, Tuttle L A & Viera A J (2013). Hypertension. Prim Care Clin Office Pract, 40, 179-194. Definition Blood Pressure (BP) Classification: BP is defined by four (4) BP reading classifications: Normal, Pre-Hypertensive, First Hypertensive, and Second Hypertensive Readings Recommended BP Follow-Up: The Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) recommends BP screening intervals, lifestyle modifications and interventions based on the current BP reading as listed in the "Recommended Blood Pressure Follow-Up Interventions" listed below Recommended Lifestyle Modifications: The JNC 7 report outlines lifestyle modifications which must include one or more of the following as indicated: * Weight Reduction * Dietary Approaches to Stop Hypertension (DASH) Eating Plan * Dietary Sodium Restriction * Increased Physical Activity * Moderation in alcohol (ETOH) Consumption Second Hypertensive Reading: Requires a BP reading of Systolic BP >= 140 mmhg OR Diastolic BP >= 90 mmhg during the current encounter AND a most recent BP reading within the last 12 months Systolic BP >= 140 mmhg OR Diastolic BP >= 90 mmhg Second Hypertensive Reading BP Interventions: The JNC 7 report outlines BP follow-up interventions for a second hypertensive BP reading and must include one or more of the following as indicated: * Anti-Hypertensive Pharmacologic Therapy * Laboratory Tests * Electrocardiogram (ECG) Recommended Blood Pressure Follow-Up Interventions: * Normal BP: No follow-up required for Systolic BP < 120 mmhg AND Diastolic BP <80 mmhg * Pre-Hypertensive BP: Follow-up with rescreen every year with systolic BP of 120-139 mmhg OR diastolic BP of 80-89 mmhg AND recommend lifestyle modifications OR referral to Alternative/Primary Care Provider * First Hypertensive BP Reading: Patients with one elevated reading of systolic BP >= 140 mmhg OR diastolic BP >= 90 mmhg: * Follow-up with rescreen > 1 day and < 4 weeks AND recommend lifestyle modifications OR referral to Alternative/Primary Care Provider * Second Hypertensive BP Reading: Patients with second elevated reading of systolic BP >=140 mmhg OR diastolic BP >= 90 mmhg: * Follow-up with Recommended lifestyle recommendations AND one or more of the Second Hypertensive Reading Interventions OR referral to Alternative/Primary Care Provider Guidance Both the systolic and diastolic blood pressure measurements are required for inclusion. If there are multiple blood pressures on the same date of service, use the most recent as the representative blood pressure. Eligible professionals who report the measure must perform the blood pressure screening at the time of a qualifying visit by an eligible professional and may not obtain measurements from external sources.

The intent of this measure is to screen patients for high blood pressure and provide recommended follow-up as indicated. The documented follow-up plan must be related to the current BP reading as indicated, example: "Patient referred to primary care provider for BP management." Transmission Format Initial Population Denominator Denominator Exclusions Numerator Numerator Exclusions Denominator Exceptions TBD All patients aged 18 years and older before the start of the measurement period with at least one eligible encounter during the measurement period Equals Initial Population Patient has an active diagnosis of hypertension Patients who were screened for high blood pressure AND have a recommended follow-up plan documented, as indicated if the blood pressure is pre-hypertensive or hypertensive Not Applicable Patient Reason(s): Patient refuses to participate (either BP measurement or follow-up) OR Medical Reason(s): Patient is in an urgent or emergent medical situation where time is of the essence and to delay treatment would jeopardize the patient's health status. This may include but is not limited to severely elevated BP when immediate medical treatment is indicated. Supplemental Data Elements For every patient evaluated by this measure also identify payer, race, ethnicity and sex Table of Contents Population Criteria Data Criteria (QDM Variables) Data Criteria (QDM Data Elements) Supplemental Data Elements Risk Adjustment Variables Population Criteria Initial Population = Age>= 18 year(s) at: "Measurement Period" "Occurrence A of Encounter, Performed: BP during "Measurement Period" Denominator = Initial Population Denominator Exclusions = "Diagnosis: Diagnosis of hypertension" starts before start of "Occurrence A of Encounter, Performed: BP Numerator = Most Recent: "Occurrence A of Encounter, Performed: BP satisfies all: overlaps "Physical Exam, Performed: Diastolic Blood Pressure (result)" overlaps "Physical Exam, Performed: Systolic Blood Pressure (result)" "Physical Exam, Performed: Systolic Blood Pressure" satisfies all: BP Screening (result < 120 mmhg) "Physical Exam, Performed: Diastolic Blood Pressure" satisfies all: BP Screening (result < 80 mmhg) "Physical Exam, Performed: Systolic Blood Pressure" satisfies all: BP (result >= 120 mmhg) (result < 140 mmhg) "Physical Exam, Performed: Diastolic Blood Pressure" satisfies

all: BP (result < 90 mmhg) "Physical Exam, Performed: Diastolic Blood Pressure" satisfies all: BP (result >= 80 mmhg) (result < 90 mmhg) "Physical Exam, Performed: Systolic Blood Pressure" satisfies all: BP (result < 140 mmhg) "Intervention, Order: Referral to Alternative Provider / Primary Care Provider (reason: Finding of Hypertension)" <= 1 day(s) starts after or concurrent with start of "Occurrence A of Encounter, Performed: BP Screening $HypertensionRecommendations <= 1 day(s) starts after or concurrent with start of "Occurrence A of Encounter, Performed: BP "Intervention, Order: Followup within one year (reason: Finding of Hypertension)" <= 1 day(s) starts after or concurrent with start of "Occurrence A of Encounter, Performed: BP Screening Encounter Codes" AND NOT: "Physical Exam, Performed: Systolic Blood Pressure (result)" < 1 year(s) starts before start of "Occurrence A of Encounter, Performed: BP AND NOT: "Physical Exam, Performed: Diastolic Blood Pressure (result)" < 1 year(s) starts before start of "Occurrence A of Encounter, Performed: BP "Physical Exam, Performed: Systolic Blood Pressure" satisfies all: Encounter, Performed: BP (result < 140 mmhg) "Physical Exam, Performed: Diastolic Blood Pressure" satisfies all: Encounter, Performed: BP (result < 90 mmhg) "Physical Exam, Performed: Systolic Blood Pressure" satisfies all: BP (result >= 140 mmhg) "Physical Exam, Performed: Diastolic Blood Pressure" satisfies all: BP (result >= 90 mmhg) "Intervention, Order: Referral to Alternative Provider / Primary Care Provider (reason: Finding of Hypertension)" <= 1 day(s) starts after or concurrent with start of "Occurrence A of Encounter, Performed: BP Screening $HypertensionRecommendations <= 1 day(s) starts after or concurrent with start of "Occurrence A of Encounter, Performed: BP "Intervention, Order: Followup within 4 weeks (reason: Finding of Hypertension)" <= 1 day(s) starts after or concurrent with start of "Occurrence A of Encounter, Performed: BP Screening Encounter Codes" "Physical Exam, Performed: Systolic Blood Pressure" satisfies all: Encounter, Performed: BP (result >= 140 mmhg) "Physical Exam, Performed: Diastolic Blood Pressure" satisfies all:

Encounter, Performed: BP (result >= 90 mmhg) "Physical Exam, Performed: Systolic Blood Pressure" satisfies all: BP (result >= 140 mmhg) "Physical Exam, Performed: Diastolic Blood Pressure" satisfies all: BP (result >= 90 mmhg) "Intervention, Order: Referral to Alternative Provider / Primary Care Provider (reason: Finding of Hypertension)" <= 1 day(s) starts after or concurrent with start of "Occurrence A of Encounter, Performed: BP Screening $HypertensionRecommendations <= 1 day(s) starts after or concurrent with start of "Occurrence A of Encounter, Performed: BP Union of: "Medication, Order: Anti-Hypertensive Pharmacologic Therapy" "Laboratory Test, Order: Laboratory Tests for Hypertension" "Diagnostic Study, Order: ECG 12 lead or study order" <= 1 day(s) starts after or concurrent with start of "Occurrence A of Encounter, Performed: BP Numerator Exclusions = Denominator Exceptions = Union of: "Physical Exam, Performed not done: Medical or Other reason not done" for "Diastolic Blood Pressure" "Physical Exam, Performed not done: Patient Reason refused" for "Diastolic Blood Pressure" "Physical Exam, Performed not done: Medical or Other reason not done" for "Systolic Blood Pressure" "Physical Exam, Performed not done: Patient Reason refused" for "Systolic Blood Pressure" starts during "Occurrence A of Encounter, Performed: BP Union of: "Intervention, Order not done: Patient Reason refused" for "Referral to Alternative Provider / Primary Care Provider" "Intervention, Order not done: Patient Reason refused" for "Lifestyle Recommendation" "Intervention, Order not done: Patient Reason refused" for "Weight Reduction Recommended" "Intervention, Order not done: Patient Reason refused" for "Dietary Recommendations" "Intervention, Order not done: Patient Reason refused" for "Physical Activity Recommendation" "Intervention, Order not done: Patient Reason refused" for "Moderation of ETOH Consumption Recommendation" "Medication, Order not done: Patient Reason refused" for "Anti-Hypertensive Pharmacologic Therapy" "Laboratory Test, Order not done: Patient Reason refused" for "Laboratory Tests for Hypertension" "Diagnostic Study, Order not done: Patient Reason refused" for "ECG 12 lead or study order" <= 1 day(s) starts after or concurrent with start of "Occurrence A of Encounter, Performed: BP Stratification = Data Criteria (QDM Variables) $HypertensionRecommendations = Union of: "Intervention, Order: Lifestyle Recommendation" "Intervention, Order: Weight Reduction Recommended" "Intervention, Order: Dietary Recommendations" "Intervention, Order: Physical Activity Recommendation" "Intervention, Order: Moderation of ETOH Consumption Recommendation" Data Criteria (QDM Data Elements) "Diagnosis: Diagnosis of hypertension" using "Diagnosis of hypertension Grouping Value Set (2.16.840.1.113883.3.600.263)" "Diagnostic Study, Order: ECG 12 lead or study order" using "ECG 12 lead or study order Grouping Value Set (2.16.840.1.113883.3.600.2448)" "Diagnostic Study, Order not done: Patient Reason refused" using "Patient Reason refused SNOMEDCT Value Set (2.16.840.1.113883.3.600.791)"

"Encounter, Performed: BP using "BP Screening Encounter Codes Grouping Value Set (2.16.840.1.113883.3.600.1920)" "Intervention, Order: Dietary Recommendations" using "Dietary Recommendations Grouping Value Set (2.16.840.1.113883.3.600.1515)" "Intervention, Order: Followup within 4 weeks" using "Followup within 4 weeks SNOMEDCT Value Set (2.16.840.1.113883.3.600.1537)" "Intervention, Order: Followup within one year" using "Followup within one year SNOMEDCT Value Set (2.16.840.1.113883.3.600.1474)" "Intervention, Order: Lifestyle Recommendation" using "Lifestyle Recommendation SNOMEDCT Value Set (2.16.840.1.113883.3.600.1508)" "Intervention, Order: Moderation of ETOH Consumption Recommendation" using "Moderation of ETOH Consumption Recommendation SNOMEDCT Value Set (2.16.840.1.113883.3.600.823)" "Intervention, Order: Physical Activity Recommendation" using "Physical Activity Recommendation Grouping Value Set (2.16.840.1.113883.3.600.1518)" "Intervention, Order: Referral to Alternative Provider / Primary Care Provider" using "Referral to Alternative Provider / Primary Care Provider SNOMEDCT Value Set (2.16.840.1.113883.3.600.1475)" "Intervention, Order: Weight Reduction Recommended" using "Weight Reduction Recommended Grouping Value Set (2.16.840.1.113883.3.600.1510)" "Intervention, Order not done: Patient Reason refused" using "Patient Reason refused SNOMEDCT Value Set (2.16.840.1.113883.3.600.791)" "Laboratory Test, Order: Laboratory Tests for Hypertension" using "Laboratory Tests for Hypertension Grouping Value Set (2.16.840.1.113883.3.600.1482)" "Laboratory Test, Order not done: Patient Reason refused" using "Patient Reason refused SNOMEDCT Value Set (2.16.840.1.113883.3.600.791)" "Medication, Order: Anti-Hypertensive Pharmacologic Therapy" using "Anti-Hypertensive Pharmacologic Therapy RXNORM Value Set (2.16.840.1.113883.3.600.1476)" "Medication, Order not done: Patient Reason refused" using "Patient Reason refused SNOMEDCT Value Set (2.16.840.1.113883.3.600.791)" "Physical Exam, Performed: Diastolic Blood Pressure" using "Diastolic Blood Pressure Grouping Value Set (2.16.840.1.113883.3.526.3.1033)" "Physical Exam, Performed: Systolic Blood Pressure" using "Systolic Blood Pressure Grouping Value Set (2.16.840.1.113883.3.526.3.1032)" "Physical Exam, Performed not done: Medical or Other reason not done" using "Medical or Other reason not done SNOMEDCT Value Set (2.16.840.1.113883.3.600.1.1502)" "Physical Exam, Performed not done: Patient Reason refused" using "Patient Reason refused SNOMEDCT Value Set (2.16.840.1.113883.3.600.791)" Attribute: "Reason: Finding of Hypertension" using "Finding of Hypertension SNOMEDCT Value Set (2.16.840.1.113883.3.600.2395)" Supplemental Data Elements "Patient Characteristic Ethnicity: Ethnicity" using "Ethnicity CDCREC Value Set (2.16.840.1.114222.4.11.837)" "Patient Characteristic Payer: Payer" using "Payer SOP Value Set (2.16.840.1.114222.4.11.3591)" "Patient Characteristic Race: Race" using "Race CDCREC Value Set (2.16.840.1.114222.4.11.836)" "Patient Characteristic Sex: ONC Administrative Sex" using "ONC Administrative Sex AdministrativeGender Value Set (2.16.840.1.113762.1.4.1)" Risk Adjustment Variables Measure Set Preventive Care and Screening